Watson biology: Yuxi Watson plans to invest in the production and capacity expansion project of polysaccharide conjugate vaccine, with a total investment of 695 million yuan
Financial Associated Press, Dec. 12 - Watson biology announced that the company's board meeting considered and passed the proposal. The company's holding subsidiary Yuxi Watson Biotechnology Co., Ltd. (hereinafter referred to as "Yuxi Watson") plans to invest in the production and energy expansion project of polysaccharide conjugate vaccine in Yuxi Watson vaccine Industrial Park, with a total planned investment of about 695 million yuan.
This text is a result of machine translation.
Related companies：
In-depth
Technology, Healthcare
Pure Global: The International Engine of Medical Technology Globalization
As a pioneer in international regulatory management and clinical solutions, Pure Global has evolved into an indispensable partner for medical technology companies. Through its outstanding data technology, seasoned industry expert team, and transnational capabilities, Pure Global empowers its partners to achieve global growth. Presently, Pure Global's services span more than 25 countries and regions, offering tailored solutions for the entire lifecycle of medical devices.
Sep 28, 2023 09:30 AM
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Apr 18, 2022 06:30 PM
Watson biology: 13 valent pneumococcal polysaccharide conjugate vaccine has been licensed in Morocco
Briefing Sep 02, 2021 02:06 PM
· Healthcare
Medical stocks continued to decline in the afternoon, with dongfulong falling more than 15%
Healthcare, Technology
Pharmaceutical Machine Vision Company aocheng Nets Tens of Millions in Round A
EqualOcean has learned that aocheng (Chinese: 奥乘智能), a machine vision inspection company in the pharmaceutical field, has recently closed tens of millions of CNY in round A financing.
Sep 18, 2023 11:55 AM
Briefing Jul 29, 2021 10:01 AM
Back to Hong Kong, Chinese concept stocks rose collectively, and Wanguo data rose 17.5%
See more
Read next
Insight
In-depth
Healthcare · Analysis
EqualOcean｜China's Top 20 ESG Performers Among Private Enterprises（Part III）
Sep 28, 2023 10:00 AM